Hemp Beyond CBD: New CBDV Tincture released by Rhizo Sciences
Txylo.com/10281871

DALLAS - Txylo -- Rhizo Sciences, a leader in hemp-derived wellness products, is excited to announce the launch of its new CBDV/CBD tincture. This innovative product combines the unique benefits of Cannabidivarin (CBDV) and Cannabidiol (CBD), marking a significant advancement in the wellness industry.

A New Era in Hemp Products Beyond CBD

The CBDV/CBD tincture from Rhizo Sciences brings together the unique properties of CBDV and CBD. This tincture is designed to provide a balanced and comprehensive wellness solution.

Dallas McMillan, CEO of Rhizo Sciences, states:
"Our new CBDV/CBD tincture represents the forefront of hemp wellness. By integrating these two cannabinoids, we provide our customers with a high-quality product. This launch highlights our commitment to innovation and our dedication to delivering top-quality wellness solutions."

More on Txylo.com

• Representative Ken King Leads Passage of Legislation to Protect Texas Women and Children
• Top 10 Largest Roofing-Related OSHA Penalties of 2024
• Mitsubishi Logisnext Americas Set to Open Customer Experience Center at Houston Campus Next Year
• Nexodus Inc. Launches Nationwide Remote Summer Internship Program
• Texas Sets New Records For Total Jobs, Texans Working, Total Labor Force

Product Highlights:

- CBDV/CBD Tincture: A balanced blend of CBDV and CBD, formulated to support overall wellness.
- Oregon Grown Hemp: This product is derived from Oregon grown hemp and undergo rigorous third-party testing to ensure purity and potency.
- Variety of Forms: In addition to tinctures, the product line includes oils, capsules, and topicals to meet diverse preferences and needs.
- Full Spectrum and Isolate Options: Customers can choose between full-spectrum products, which include a range of cannabinoids and terpenes, or pure isolates for targeted benefits.

Educational Resources and Community Engagement
To help consumers understand the benefits of CBDV and CBD, Rhizo Sciences has launched a series of educational materials, including blog posts, videos and techincal information on cannabinoids and hemp processing available on our Hempex.com website (http://www.hempex.com). We invite our community to engage with us on social media and share their experiences using the new CBDV/CBD tincture.

More on Txylo.com

• $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
• LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
• Marc Soucy's Newest Music Series Approaches Its One Year Mark
• Border Briefs Launch: New Series Highlights the Complexities and Opportunities of the U.S.-Mexico Border
• Fairmint Releases Whitepaper for Open Captable Protocol (OCP) to Advance On-Chain Equity Securities

Looking Ahead

The introduction of the CBDV/CBD tincture marks an exciting new chapter for Rhizo Sciences. We are committed to advancing cannabinoid science and exploring its full potential in promoting health and wellness. Stay tuned for more innovative products and research updates, including acid form CBDVA products.

About Rhizo Sciences

Rhizo Sciences is a pioneer in the hemp industry, dedicated to providing high-quality, hemp-derived products. Our focus on innovation, transparency, and sustainability drives our product development and customer satisfaction.
**FDA Disclaimer:**
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

By launching this new product line, Rhizo Sciences continues to lead the way in hemp-based consumer products which are easy to take and go beyond CBD.